Recurrence of sarcoid granulomas in lung transplant recipients is common and does not affect overall survival

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 31, Issue 2, 2014, Pages 149-153

  Schultz, H H ^a   Andersen, C B ^a   Steinbruchel D ^a   Perch, M ^a   Carlsen, J ^a   Iversen, M ^a  

^a University of Copenhagen   (Denmark)

Author keywords

Biopsies; Sarcoidosis; Transplantation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; GIANT CELL; GRAFT RECIPIENT; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG GRANULOMA; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY; TRANSBRONCHIAL BIOPSY; TUMOR RECURRENCE; ADVERSE EFFECTS; BIOPSY; COMPARATIVE STUDY; DENMARK; GRANULOMA, RESPIRATORY TRACT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RISK FACTOR; SARCOIDOSIS, PULMONARY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; BIOPSY; DENMARK; FEMALE; GRANULOMA, RESPIRATORY TRACT; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOIDOSIS, PULMONARY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907369710     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am.J.Respir.Crit Care Med. 1999 Aug; 160(2): 736-55.
2. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Kotloff R, et al. International guidelines for the selection of lung transplant candidates: 2006 update-A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J.Heart Lung Transplant. 2006 Jul; 25(7): 745-55.
3. Shah PD, Orens JB. Guidelines for the selection of lung-Transplant candidates. Curr.Opin.Organ Transplant. 2012 Oct; 17(5): 467-73.
4. Milman N, Andersen CB, Burton CM, IversenM. Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells. Eur.Respir.J. 2005 Sep; 26(3): 549-52.
5. Ionescu DN, Hunt JL, Lomago D, Yousem SA. Recurrent sarcoidosis in lung transplant allografts: granulomas are of recipient origin. Diagn.Mol.Pathol. 2005 Sep; 14(3): 140-5.
6. Nunley DR,Hattler B, Keenan RJ, Iacono AT, Yousem S, Ohori NP, Dauber JH. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis.Vasc. Diffuse.Lung Dis. 1999 Mar; 16(1): 93-100.
7. Burton CM, Milman N, Carlsen J, Arendrup H, Eliasen K, Andersen CB, Iversen M. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J.Heart Lung Transplant. 2005 Nov; 24(11): 1834-43.
8. Burton CM, Andersen CB, Jensen AS, Iversen M,Milman N, Boesgaard S, Arendrup H, Eliasen K, Carlsen J. The incidence of acute cellular rejection after lung transplantation: a comparative study of anti-Thymocyte globulin and daclizumab. J.Heart Lung Transplant. 2006 Jun; 25(6): 638-47.
9. Burton CM, Kristensen P, Lutzhoft R, Rasmussen M, Milman N, Carlsen J, Christiansen CB, Andersen CB, Iversen M. Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching. Scand.J.Infect.Dis. 2006; 38(4): 281-9.
10. Burton CM, Iversen M, Scheike T, Carlsen J, Andersen CB. Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation. J.Heart Lung Transplant. 2008 Oct; 27(10): 1128-34.
11. Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH,Marchevsky A, Ohori NP, Ritter J, Stewart S, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J.Heart Lung Transplant. 1996 Jan; 15(1 Pt 1): 1-15.
12. Stewart S, FishbeinMC, Snell GI, Berry GJ, Boehler A, BurkeMM, Glanville A, Gould FK,Magro C,Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J.Heart Lung Transplant. 2007 Dec; 26(12): 1229-42.
13. Estenne M,Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M,Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J.Heart Lung Transplant. 2002 Mar; 21(3): 297-310.
14. Wille KM, Gaggar A, Hajari AS, Leon KJ, Barney JB, Smith KH, Pajaro O, Wang W, Oster RA, McGiffin DC, et al. Bronchiolitis obliterans syndrome and survival following lung transplantation for patients with sarcoidosis. Sarcoidosis.Vasc.Diffuse.Lung Dis. 2008 Dec; 25(2): 117-24.
15. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J.Heart Lung Transplant. 2012 Oct; 31(10): 1073-86.
16. Nakajima T, Yasufuku K, Kurosu K, Takiguchi Y, Fujiwara T, Chiyo M, Shibuya K, Hiroshima K, Nakatani Y, Yoshino I. The role of EBUS-TBNA for the diagnosis of sarcoidosis-comparisons with other bronchoscopic diagnostic modalities. Respir.Med. 2009 Dec; 103(12): 1796-800.
17. OkiM, Saka H, Kitagawa C, Kogure Y,Murata N, Ichihara S,Moritani S. Prospective study of endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue for diagnosis of sarcoidosis. J.Thorac.Cardiovasc.Surg. 2012 Jun; 143(6): 1324-9.
18. Plit M, Pearson R, Havryk A, Da CJ, Chang C, Glanville AR. Diagnostic utility of endobronchial ultrasound-guided transbronchial needle aspiration compared with transbronchial and endobronchial biopsy for suspected sarcoidosis. Intern.Med.J. 2012 Apr; 42(4): 434-8.
19. Uber PA, Ross HJ, Zuckermann AO, Sweet SC, Corris PA,McNeil K, Mehra MR. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory. J.Heart Lung Transplant. 2009 Jul; 28(7): 655-60.
20. Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert.Rev.Clin.Immunol. 2012 Jan; 8(1): 95-103.
21. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin.Chest Med. 2008 Sep; 29(3): 533-x.
22. Baughman RP, Nunes H, Sweiss NJ, Lower EE. Established and experimental medical therapy of pulmonary sarcoidosis. Eur.Respir.J. 2013 Feb 8.
23. Baughman RP, Lower EE. Steroid-sparing alternative treatments for sarcoidosis. Clin.Chest Med. 1997 Dec; 18(4): 853-64.
24. Paramothayan S, Lasserson TJ,Walters EH. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis. Cochrane. Database. Syst. Rev. 2006; (3): CD003536.